Potential Vascular and Bleeding Complications of Treatment With Selective Serotonin Reuptake Inhibitors
- 1 January 1996
- journal article
- review article
- Published by Elsevier in Psychosomatics
- Vol. 37 (1) , 12-16
- https://doi.org/10.1016/s0033-3182(96)71592-x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Bleeding attributed to the intake of paroxetineAmerican Journal of Psychiatry, 1994
- Serotonergic mechanisms and the new antidepressantsPsychological Medicine, 1993
- Abnormal Platelet Aggregation Associated with Fluoxetine TherapyAnnals of Pharmacotherapy, 1992
- Adverse vascular effects associated with fluoxetineAmerican Journal of Psychiatry, 1992
- Effects of acute and chronic treatment with fluvoxamine on extracellular and platelet serotonin in the blood of major depressive patients. Relationship to clinical improvementJournal of Affective Disorders, 1992
- Effects of monoamine uptake inhibitors on extracellular and platelet 5‐hydroxytryptamine in rat blood: different effects of clomipramine and fluoxetineBritish Journal of Pharmacology, 1992
- Bleeding, a side effect of fluoxetineAmerican Journal of Psychiatry, 1992
- Drug-induced supraventricular tachycardia: A case report of fluoxetineAnnals of Emergency Medicine, 1991
- Serotonin in body fluids: Characterization of human plasmatic and cerebrospinal fluid pools by means of a new HPLC methodLife Sciences, 1985
- Inhibition of 5-hydroxytryptamine uptake in human platelets by antidepressant agents in vivoPsychopharmacology, 1980